US 11311532
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted A61KA61K31/4745A61K47/02
Quick answer
US patent 11311532 (High dosage valbenazine formulation and compositions, methods, and kits related thereto) held by Neurocrine Biosciences, Inc. expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/4745, A61K47/02, A61K47/12, A61K47/26